Rocket Pharmaceuticals, Inc.(RCKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RCKT Rocket Pharmaceuticals, Inc.

交易中 12-19 14:18:00 EST

3.23

+0.00

0.00%

最高3.28	最低3.20	成交量100.47万
今开3.22	昨收3.23	日振幅2.48%
总市值3.50亿	流通市值2.54亿	总股本1.08亿
成交额325.67万	换手率1.28%	流通股本7,879万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RCKT","market":"US","secType":"STK","nameCN":"Rocket Pharmaceuticals, Inc.","latestPrice":3.23,"timestamp":1766171875341,"preClose":3.23,"halted":0,"volume":1004672,"delay":0,"floatShares":78786291,"shares":108222228,"eps":-2.239737,"marketStatus":"交易中","change":0,"latestTime":"12-19 14:18:00 EST","open":3.22,"high":3.28,"low":3.2,"amount":3256666.1898496,"amplitude":0.024768,"askPrice":3.23,"askSize":1836,"bidPrice":3.22,"bidSize":1982,"shortable":3,"etf":0,"ttmEps":-2.239737,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766178000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1424235600000,"exchange":"NASDAQ","adjPreClose":3.23,"preHourTrading":{"tag":"盘前","latestPrice":3.23,"preClose":3.23,"latestTime":"09:29 EST","volume":1231,"amount":4006.7331524,"timestamp":1766154544073},"postHourTrading":{"tag":"盘后","latestPrice":3.2109,"preClose":3.23,"latestTime":"18:16 EST","volume":17586,"amount":56891.856,"timestamp":1766099785364},"volumeRatio":0.694813,"impliedVol":1.8241,"impliedVolPercentile":0.78},"requestUrl":"/m/hq/s/RCKT","defaultTab":"news","newsList":[{"id":"2584917071","title":"Rocket Pharmaceuticals, Inc.盘中异动 快速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584917071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584917071?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:30","pubTimestamp":1763476213,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时30分，Rocket Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.26%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为916.95%、351.64%、263.93%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Oric Pharmaceuticals, Inc.、Aligos Therapeutics, Inc.，振幅分别为4.67%、3.40%、2.92%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223013a702236b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223013a702236b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2581343856","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.54%报3.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581343856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581343856?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:37","pubTimestamp":1762526223,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时37分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.54%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。消息层面，截至22时37分，《Needham维持Rocket Pharmaceuticals持有评级》资讯为影响Rocket Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722370394f5ea77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722370394f5ea77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2577682156","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.12%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577682156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577682156?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:37","pubTimestamp":1760967428,"startTime":"0","endTime":"0","summary":"北京时间2025年10月20日21时37分，Rocket Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.12%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。公司的管线产品包括用于治疗 Danaon 病的 RP-A501、用于治疗范可尼贫血的 RP-L102、用于治疗白细胞黏附缺陷的 RP-L201、用于治疗丙酮酸激酶缺乏症的 RP-L301 以及用于治疗婴儿恶性骨硬化症的 RP-L401。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020213708a6c3e29f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020213708a6c3e29f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"1181492790","title":"Rocket Pharmaceuticals宣布FDA接受Kresladi™治疗严重白细胞粘附缺陷症-I(LAD-I)的生物制品许可申请重新提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1181492790","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181492790?lang=zh_cn&edition=full","pubTime":"2025-10-14 19:00","pubTimestamp":1760439654,"startTime":"0","endTime":"0","summary":"Rocket Pharmaceuticals宣布FDA接受Kresladi™治疗严重白细胞粘附缺陷症-I(LAD-I)的生物制品许可申请重新提交","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"1150569659","title":"Rocket Pharmaceuticals, Inc.任命Martin Wilson为临时首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1150569659","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150569659?lang=zh_cn&edition=full","pubTime":"2025-08-26 04:09","pubTimestamp":1756152591,"startTime":"0","endTime":"0","summary":"Rocket Pharmaceuticals, Inc.宣布任命Martin Wilson担任公司临时首席财务官一职。该任命信息已提交至美国证券交易委员会(SEC)备案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"1153539345","title":"Rocket Pharmaceuticals Inc：美银全球研究将评级从中性上调至买入，目标价从4美元上调至10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153539345","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153539345?lang=zh_cn&edition=full","pubTime":"2025-08-21 19:18","pubTimestamp":1755775121,"startTime":"0","endTime":"0","summary":"Rocket Pharmaceuticals Inc获得美银全球研究评级上调，从此前的中性评级升至买入评级，同时将目标价从4美元大幅上调至10美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2558664840","title":"Rocket Pharmaceuticals, Inc.盘中异动 快速上涨5.07%报3.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558664840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558664840?lang=zh_cn&edition=full","pubTime":"2025-08-12 00:03","pubTimestamp":1754928184,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日00时03分，Rocket Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.07%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5788.16%、545.97%、185.33%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081200030497411d70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081200030497411d70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2557520497","title":"Rocket Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557520497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557520497?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:52","pubTimestamp":1754661124,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时52分，Rocket Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.02%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Bioxcel Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Nucana Plc涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为241.06%、101.00%、89.81%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cognition Therapeutics, Inc.，振幅分别为45.00%、30.00%、26.50%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821520494d7d18b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821520494d7d18b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2555477020","title":"Rocket Pharmaceuticals, Inc.盘中异动 股价大涨7.97%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555477020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555477020?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:31","pubTimestamp":1753882282,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时31分，Rocket Pharmaceuticals, Inc.股票出现异动，股价快速上涨7.97%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。其相关个股中，Replimune Group, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Tnf Pharmaceuticals, Inc.、Imunon, Inc.、Replimune Group, Inc.较为活跃，换手率分别为182.97%、78.72%、76.64%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Aclaris Therapeutics, Inc.、Upstream Bio, Inc.，振幅分别为36.81%、10.32%、8.02%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213123a6c9d48f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213123a6c9d48f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2552875434","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘股价大涨19.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552875434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552875434?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:31","pubTimestamp":1752759067,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时31分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速拉升19.58%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Briacell Therapeutics Corp C/Wts 涨幅较大，Windtree Therapeutics, Inc.、Immuron Limited、Abpro Holdings, Inc较为活跃，换手率分别为388.01%、176.25%、104.37%，振幅较大的相关个股有Jupiter Neurosciences, Inc.、Tnf Pharmaceuticals, Inc.、Vyne Therapeutics Inc.，振幅分别为15.80%、10.18%、7.94%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213107a6aff593&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213107a6aff593&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":1},{"id":"2550659932","title":"Rocket Pharmaceuticals, Inc.盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659932?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:58","pubTimestamp":1752073118,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时58分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.00%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1161.25%、714.98%、534.59%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.，振幅分别为173.13%、112.02%、64.08%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225838979fc9a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225838979fc9a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2548883342","title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883342?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:19","pubTimestamp":1751383169,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时19分，Rocket Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.25%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Neurogene Inc.、Atai Life Sciences N.V.涨幅较大，Oragenics Inc.、Soligenix, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1863.65%、1379.07%、194.22%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Soligenix, Inc.，振幅分别为69.61%、55.78%、43.51%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012319299532b6ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012319299532b6ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2546326245","title":"Rocket Pharmaceuticals, Inc.6月24日成交额为1107.71万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546326245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546326245?lang=zh_cn&edition=full","pubTime":"2025-06-25 13:15","pubTimestamp":1750828540,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Rocket Pharmaceuticals, Inc.成交额为1107.71万美元，成交额较昨日增加26.72%，当日成交量为400.82万股。Rocket Pharmaceuticals, Inc.于2025年6月24日涨5.32%，报2.77美元，该股过去5个交易日跌3.82%，年初至今跌77.96%，过去60日跌64.85%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-24|1107.71万|26.72%|400.82万|#|2025-06-23|874.17万|-55.65%|331.12万|#|2025-06-20|1971.28万|54.29%|723.32万|#|2025-06-18|1277.67万|8.24%|450.28万|#|2025-06-17|1180.40万|1.54%|424.13万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625131543a71c6190&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625131543a71c6190&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2545471788","title":"Rocket Pharmaceuticals, Inc.6月23日成交额为874.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545471788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545471788?lang=zh_cn&edition=full","pubTime":"2025-06-24 13:14","pubTimestamp":1750742069,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日，Rocket Pharmaceuticals, Inc.成交额为874.17万美元，成交额较昨日减少55.65%，当日成交量为331.12万股。Rocket Pharmaceuticals, Inc.于2025年6月23日跌2.59%，报2.63美元，该股过去5个交易日跌10.24%，年初至今跌79.08%，过去60日跌65.8%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-23|874.17万|-55.65%|331.12万|#|2025-06-20|1971.28万|54.29%|723.32万|#|2025-06-18|1277.67万|8.24%|450.28万|#|2025-06-17|1180.40万|1.54%|424.13万|#|2025-06-16|1162.45万|25.89%|404.31万|Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624131431a71a9658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624131431a71a9658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2544545993","title":"瑞银：维持Rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544545993","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544545993?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:50","pubTimestamp":1750168220,"startTime":"0","endTime":"0","summary":"瑞银：维持Rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至5.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17215051129250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RCKT"],"gpt_icon":0},{"id":"2517043028","title":"Rocket Pharmaceuticals, Inc.2024财年实现净利润-2.59亿美元，同比减少5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517043028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517043028?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363252,"startTime":"0","endTime":"0","summary":"3月8日，Rocket Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-2.59亿美元，同比减少5.28%；其中营业收入为0.00美元，每股基本收益为-2.73美元。从资产负债表来看，Rocket Pharmaceuticals, Inc.总负债64.47百万美元，其中短期债务2.86百万美元，资产负债比为0.09，流动比率为0.10。机构评级：截至2025年3月8日，当前有14家机构对Rocket Pharmaceuticals, Inc.目标价做出预测，其中目标均价为39.86美元，其中最低目标价为15.00美元，最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000226abed6696&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000226abed6696&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT"],"gpt_icon":0},{"id":"2517427639","title":"Rocket Pharmaceuticals, Inc.盘中异动 急速上涨5.02%报9.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517427639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517427639?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:23","pubTimestamp":1741195422,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时23分，Rocket Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.02%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为934.29%、303.67%、291.71%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306012342a260f792&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306012342a260f792&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCKT"],"gpt_icon":0},{"id":"2516668785","title":"Rocket Pharmaceuticals, Inc.盘中异动 下午盘快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668785?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:09","pubTimestamp":1741032562,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时09分，Rocket Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.03%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4586.34%、212.52%、182.79%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc 是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040922abe690da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040922abe690da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCKT","BK4139"],"gpt_icon":0},{"id":"2516374506","title":"Scotiabank：维持Rocket Pharmaceuticals(RCKT.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由51.00美元调整至52.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516374506","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516374506?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:11","pubTimestamp":1741014689,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Rocket Pharmaceuticals(RCKT.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由51.00美元调整至52.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03231148494581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RCKT"],"gpt_icon":0},{"id":"2516742638","title":"加拿大投资银行集团：维持Rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级, 目标价由39.00美元调整至36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516742638","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516742638?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:41","pubTimestamp":1741005705,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Rocket Pharmaceuticals(RCKT.US)评级，由买入调整至买入评级, 目标价由39.00美元调整至36.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03204148492500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RCKT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rocketpharma.com","stockEarnings":[{"period":"1week","weight":-0.0638},{"period":"1month","weight":0.0986},{"period":"3month","weight":0.0521},{"period":"6month","weight":0.1963},{"period":"1year","weight":-0.7249},{"period":"ytd","weight":-0.743}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rocket Pharmaceuticals, Inc.于1999年7月7日根据特拉华州法律注册成立。该公司是一家完全整合的、处于后期阶段的生物技术公司，专注于开发首创、唯一和同类最佳的基因疗法，具有直接的靶向作用机制和明确的临床终点，用于罕见和破坏性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.066269},{"month":2,"riseRate":0.4,"avgChangeRate":-0.021166},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.066486},{"month":4,"riseRate":0.636364,"avgChangeRate":0.013738},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.036361},{"month":6,"riseRate":0.545455,"avgChangeRate":-0.005129},{"month":7,"riseRate":0.636364,"avgChangeRate":0.138772},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.027706},{"month":9,"riseRate":0.545455,"avgChangeRate":0.094103},{"month":10,"riseRate":0.545455,"avgChangeRate":0.048247},{"month":11,"riseRate":0.545455,"avgChangeRate":0.014665},{"month":12,"riseRate":0.454545,"avgChangeRate":0.095073}],"exchange":"NASDAQ","name":"Rocket Pharmaceuticals, Inc.","nameEN":"Rocket Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rocket Pharmaceuticals, Inc.(RCKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rocket Pharmaceuticals, Inc.(RCKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rocket Pharmaceuticals, Inc.,RCKT,Rocket Pharmaceuticals, Inc.股票,Rocket Pharmaceuticals, Inc.股票老虎,Rocket Pharmaceuticals, Inc.股票老虎国际,Rocket Pharmaceuticals, Inc.行情,Rocket Pharmaceuticals, Inc.股票行情,Rocket Pharmaceuticals, Inc.股价,Rocket Pharmaceuticals, Inc.股市,Rocket Pharmaceuticals, Inc.股票价格,Rocket Pharmaceuticals, Inc.股票交易,Rocket Pharmaceuticals, Inc.股票购买,Rocket Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rocket Pharmaceuticals, Inc.(RCKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rocket Pharmaceuticals, Inc.(RCKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}